The METAP2 gene helps cells trim the first building block from many newly made proteins so those proteins can fold and work properly. It also supports normal cell growth and the formation of new blood vessels. If the METAP2 gene does not work well, some proteins may not mature as expected, which can affect growth and development.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for building proteins, which are the working parts of cells. Other genes mostly help determine when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
METAP2Gene function
What if the gene works
The METAP2 gene helps cells trim the first building block from many newly made proteins. This supports normal protein function, cell growth, and routine tissue maintenance.
Risk
What if the gene does not work
Variants in the METAP2 gene are linked to a developmental condition that can affect growth, head size, learning, and development. Effects can range from milder delays to more pronounced developmental features, depending on how much gene function is reduced.
Treatment
What does that mean for your treatment
No METAP2-specific treatment or drug selection approach is currently established for people with a pathogenic variant in the METAP2 gene. METAP2 is being studied as a drug target, and METAP2 inhibitors have been explored in obesity and cancer research, but this has not led to guideline-based care for inherited METAP2 variants.
Gene function
What if the gene works
Your cells constantly make new proteins, and many need a quick finishing step before they can work properly. The METAP2 gene helps carry out that early cleanup so fresh proteins are ready for normal cell tasks. Understanding what the METAP2 gene does helps explain how cells keep everyday processes running smoothly.
METAP2 removes the first building block, called methionine, from many newly made proteins. This early trim is a normal step that helps proteins mature after they are built.
After that first trim, some proteins can receive small chemical tags that help direct where they go in the cell. This makes it easier for the right proteins to reach the right place.
METAP2 works on proteins very soon after they are made, near the cell's protein-making machinery. That timing helps cells prepare new proteins in an orderly way for everyday use.
By helping many proteins become usable, the METAP2 gene supports steady cell growth and routine tissue function. This is part of normal day-to-day cell maintenance.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and help explain normal variation among people, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic diversity. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
METAP2 gene variants can change the protein’s shape, stability, or working pocket, which may lower how well it removes the first amino acid from newly made proteins. Some variants mainly reduce activity, while more severe variants can shorten the protein or disrupt key binding sites, leading to little or no function. This range helps explain why METAP2 gene variants may have milder or stronger effects at the cellular level.
How variants are linked to conditions
The METAP2 gene does not yet have a broadly confirmed link to a specific health condition, though research on METAP2 gene variants and health conditions is still developing. Anyone with a confirmed METAP2-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are common and are a normal part of human biology. Most do not have a direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the METAP2 gene. If a METAP2 change is found, personal risk usually depends more on the exact variant and the health findings already present than on lifestyle or environmental factors.
Inheritance of METAP2 variants
For families trying to understand how variants of the METAP2 gene are inherited, there is not yet a broadly confirmed disease specific inheritance pattern used in routine clinical genetics. As research develops, this may become clearer for particular METAP2 related findings. The METAP2 gene is located on the X chromosome, so inheritance can differ between sons and daughters because children receive their X chromosome in different ways from their parents.
What does my METAP2 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific health condition for METAP2. Research on this gene is still developing, so a METAP2 result does not currently give the same clear family risk information that some other genes do. If you have a specific METAP2 result, family implications are best interpreted in the context of that exact finding.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for METAP2 variants usually uses a blood or saliva sample. A lab reads the DNA in the METAP2 gene and compares it with the usual sequence to look for differences, called variants. Results may show whether a variant was found and how clearly it can be interpreted.
When should I consider getting a genetic test?
There is not yet a broadly established, METAP2-specific reason for genetic testing in routine care. Testing decisions are usually based on your symptoms, medical history, and family history, and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can be informative, but what it reveals depends on the condition and on the type of variant. How the body functions over time is also shaped by many influences, including lifestyle, environment, age, and medical history. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, it can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people taking the same treatment may process it differently because their bodies absorb, break down, transport, or respond to a drug in slightly different ways. This is common and can influence how well a medicine works or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences shape the way a person responds to medications. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. You can learn more about this topic in the LearnHub.
Drugs influenced by the METAP2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or treatment changes are best discussed with your doctor or pharmacist.
History
METAP2 entered the research spotlight in the 1990s, when scientists studying the natural compound fumagillin found that it bound to this gene’s protein product. From these first observations, research expanded steadily. That discovery made METAP2 important in early work on blood vessel growth, especially in cancer research, because blocking this pathway seemed promising. Interest later widened to metabolic disease when drugs aimed at METAP2 were tested for weight loss and related conditions. One of the best known programs involved beloranib, which showed strong effects in studies but was later stopped after major safety concerns emerged. Today, METAP2 is remembered mainly for its role in the rise of targeted drug research.